LANSING, Mich. (WLNS) — Michigan Governor Gretchen Whitmer joined Pfizer and other leaders from the state on Monday to announce a major expansion for the company.

Whitmer said the investment will expand Pfizer’s capacity to make more potentially lifesaving vaccines and treatments in Kalamazoo.

“It’s hard to not know somebody that works at Pfizer, the pride within our community… it really puts us on the map globally, the good work that comes out of here saves millions of lives… But it’s really nice to know that they are growing and doing so well here, and are able to attract and retain the talent that is needed for these jobs,” said Portage Mayor Patricia Randall.

In total, Pfizer will be investing $750 million in its Kalamazoo facility, creating 300 jobs in the process.

“Today, Pfizer is making another bold bet on Michigan’s manufacturing strengths and hardworking people,” said Governor Whitmer. “This $750 million investment will expand capacity at their Kalamazoo facility, creating good-paying jobs and fostering long-term economic opportunity for Michiganders. We brought this investment home thanks to effective collaboration between the state and Pfizer, and I know that Michigan’s future is bright because we have world-leading companies, economic momentum, and the hardest working people on the planet to move us forward.” 

The plant has been in operation since 1948 and the 400,000-square-foot production facility already employs 3,000 colleagues and contractors, Pfizer said.

“Since 2017, Pfizer has invested $5 billion to support the ongoing growth of our manufacturing leadership in the U.S.” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “This expansion is part of our blueprint to grow our U.S. manufacturing base, create more manufacturing jobs, and help ensure patients everywhere can get the medicines they need.” 

At the press conference, Whitmer was also joined by Quentin Messer, Jr., CEO of the Michigan Economic Development Corporation, David Breen of Pfizer, local state Senators, Representatives, and other elected officials 

” This new investment will build on some of the technology platforms that were used in the manufacturing of our COVID-19 vaccine and to look for new additional products and opportunities,” said Breen.

The announcement was made at a press conference at 10 a.m. Monday in Lansing.